Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Yu Katayose

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8622-8003; OpenAlex author ID A5110052000. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2011: 3 papers · 2012: none · 2013: 3 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 12

  1. Fecal colitis obliterans and cytomegalovirus enteritis after pancreaticoduodenectomy for resectable pancreatic cancer. Last author DOI 10.1007/s12328-025-02219-7↗
  2. Expression of Corticotropin-Releasing Hormone and Its Receptors May Be Associated With Survival Rate in Pancreatic Cancer. Co-author DOI 10.1016/j.gastha.2022.09.003↗
  3. Association between chronological depressive changes and physical symptoms in postoperative pancreatic cancer patients. Co-author DOI 10.1186/s13030-018-0132-1↗
  4. MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Ste… Co-author DOI 10.1097/mpa.0000000000000778↗
  5. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis. Co-author DOI 10.1016/j.pan.2016.01.007↗
  6. [A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery]. Co-author PMID 25731467↗
  7. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded t… Co-author DOI 10.1002/ijc.27797↗
  8. Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutiona… Co-author DOI 10.1245/s10434-013-3129-9↗
  9. [A case of successful R0 resection after neoadjuvant therapy for locally advanced unresectable pancreatic cancer]. Co-author PMID 24393949↗
  10. Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study. Co-author DOI 10.1007/s10147-011-0220-8↗
  11. Severe cholestatic liver failure associated with gemcitabine adjuvant monotherapy for pancreatic cancer. Co-author DOI 10.1007/s12328-011-0257-2↗
  12. Retrospective evaluation of the influence of postoperative tumor marker status on survival and patterns of recurrence after surgery for pancreatic cancer based… Co-author DOI 10.1245/s10434-010-1311-x↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kei Nakagawa · 6 shared papers, 2013–2025 · strength 0.58
  2. Michiaki Unno · 11 shared papers, 2011–2023 · strength 0.57
  3. Fuyuhiko Motoi · 11 shared papers, 2011–2023 · strength 0.57
  4. Kei Kawaguchi · 4 shared papers, 2014–2023 · strength 0.33
  5. Shinichi Egawa · 9 shared papers, 2011–2017 · strength 0.33
  6. Naoko Sato · 2 shared papers, 2018–2023 · strength 0.24
  7. Tatsuyuki Takadate · 3 shared papers, 2011–2023 · strength 0.22
  8. Takaho Okada · 4 shared papers, 2011–2014 · strength 0.12
  9. Takanori Morikawa · 3 shared papers, 2011–2014 · strength 0.09
  10. Toshiki Rikiyama · 3 shared papers, 2011 · strength 0.08
  11. Fumiko Sato · 1 shared paper, 2018 · strength 0.08
  12. Kyohei Ariake · 1 shared paper, 2018 · strength 0.08
  13. Hiroshi Yoshida · 2 shared papers, 2013–2014 · strength 0.06
  14. Masamichi Mizuma · 2 shared papers, 2013–2014 · strength 0.06
  15. Tatsuo Hata · 1 shared paper, 2016 · strength 0.06
  16. Shuhei Kawasaki · 1 shared paper, 2017 · strength 0.06
  17. Koetsu Inoue · 1 shared paper, 2017 · strength 0.06
  18. Daisuke Douchi · 1 shared paper, 2017 · strength 0.06
  19. Tetsuya Terasaki · 1 shared paper, 2017 · strength 0.06
  20. Shimpei Maeda · 2 shared papers, 2011–2013 · strength 0.05
  21. Shinichi Yabuuchi · 1 shared paper, 2014 · strength 0.03
  22. Hajime Taniguchi · 1 shared paper, 2014 · strength 0.03
  23. Shuichi Aoki · 1 shared paper, 2013 · strength 0.03
  24. Takashi Suzuki · 1 shared paper, 2013 · strength 0.03
  25. Toshihide Nishimura · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.